b.value AG’s Post

Last week, Isabelle Schiffer, Ph.D visited our portfolio company actome in Freiburg. actome is redefining the way we approach protein detection and analysis, addressing a critical gap in the life sciences field. 🧬 While technologies for DNA and RNA have advanced significantly, the proteomics field has faced unique challenges. 𝗔𝗰𝘁𝗼𝗺𝗲’𝘀 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗜𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝗼𝗻 𝗖𝗼𝘂𝗽𝗹𝗶𝗻𝗴 (𝗣𝗜𝗖𝗢) 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗶𝘀 𝗰𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝘁𝗵𝗶𝘀 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲. 💡 Their platform enables high-throughput, absolute quantification of proteins, protein interactions, and post-translational modifications using digital PCR technology—all without the need for external standards or controls. 🙌 During the visit, the team showed us the protocols in action, and we discussed their vision for the future of proteomics. ➡️ If you’re curious to learn more about Actome, feel free to reach out to us or connect directly with the Actome team. Link to their website in the comments.

  • No alternative text description for this image
  • No alternative text description for this image

To view or add a comment, sign in

Explore topics